Delivering a smoke-free future
Our current product portfolio primarily consists of cigarettes and smoke-free products, including heated tobacco, e-vapor, and oral smokeless products.
As of December 31, 2023, 39.3 percent of our total net revenues came from our smoke-free products.
By 2030, our ambition is to increase that figure to over two-thirds, with the ultimate goal of phasing out cigarettes completely. Leveraging our scientific expertise and technological capabilities, we are also committed to developing new products in the
wellness and healthcare space.